585 related articles for article (PubMed ID: 8646779)
1. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.
Nakayama K; Ishida N; Shirane M; Inomata A; Inoue T; Shishido N; Horii I; Loh DY; Nakayama K
Cell; 1996 May; 85(5):707-20. PubMed ID: 8646779
[TBL] [Abstract][Full Text] [Related]
2. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice.
Fero ML; Rivkin M; Tasch M; Porter P; Carow CE; Firpo E; Polyak K; Tsai LH; Broudy V; Perlmutter RM; Kaushansky K; Roberts JM
Cell; 1996 May; 85(5):733-44. PubMed ID: 8646781
[TBL] [Abstract][Full Text] [Related]
3. CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis.
Franklin DS; Godfrey VL; Lee H; Kovalev GI; Schoonhoven R; Chen-Kiang S; Su L; Xiong Y
Genes Dev; 1998 Sep; 12(18):2899-911. PubMed ID: 9744866
[TBL] [Abstract][Full Text] [Related]
4. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).
Kiyokawa H; Kineman RD; Manova-Todorova KO; Soares VC; Hoffman ES; Ono M; Khanam D; Hayday AC; Frohman LA; Koff A
Cell; 1996 May; 85(5):721-32. PubMed ID: 8646780
[TBL] [Abstract][Full Text] [Related]
5. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1).
Martín A; Odajima J; Hunt SL; Dubus P; Ortega S; Malumbres M; Barbacid M
Cancer Cell; 2005 Jun; 7(6):591-8. PubMed ID: 15950907
[TBL] [Abstract][Full Text] [Related]
6. Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors.
Takeuchi S; Koeffler HP; Hinton DR; Miyoshi I; Melmed S; Shimon I
J Endocrinol; 1998 May; 157(2):337-41. PubMed ID: 9659297
[TBL] [Abstract][Full Text] [Related]
7. p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation.
Teixeira LT; Kiyokawa H; Peng XD; Christov KT; Frohman LA; Kineman RD
Oncogene; 2000 Apr; 19(15):1875-84. PubMed ID: 10773877
[TBL] [Abstract][Full Text] [Related]
8. Inhibin and p27 interact to regulate gonadal tumorigenesis.
Cipriano SC; Chen L; Burns KH; Koff A; Matzuk MM
Mol Endocrinol; 2001 Jun; 15(6):985-96. PubMed ID: 11376116
[TBL] [Abstract][Full Text] [Related]
9. p27(Kip1) regulates cell cycle withdrawal of late multipotent progenitor cells in the mammalian retina.
Levine EM; Close J; Fero M; Ostrovsky A; Reh TA
Dev Biol; 2000 Mar; 219(2):299-314. PubMed ID: 10694424
[TBL] [Abstract][Full Text] [Related]
10. p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice.
Park MS; Rosai J; Nguyen HT; Capodieci P; Cordon-Cardo C; Koff A
Proc Natl Acad Sci U S A; 1999 May; 96(11):6382-7. PubMed ID: 10339596
[TBL] [Abstract][Full Text] [Related]
11. Role for p27(Kip1) in Vascular Smooth Muscle Cell Migration.
Sun J; Marx SO; Chen HJ; Poon M; Marks AR; Rabbani LE
Circulation; 2001 Jun; 103(24):2967-72. PubMed ID: 11413088
[TBL] [Abstract][Full Text] [Related]
12. Genetic evidence for the interactions of cyclin D1 and p27(Kip1) in mice.
Tong W; Pollard JW
Mol Cell Biol; 2001 Feb; 21(4):1319-28. PubMed ID: 11158317
[TBL] [Abstract][Full Text] [Related]
13. Persistent and heterogenous expression of the cyclin-dependent kinase inhibitor, p27KIP1, in rat hearts during development.
Koh KN; Kang MJ; Frith-Terhune A; Park SK; Kim I; Lee CO; Koh GY
J Mol Cell Cardiol; 1998 Mar; 30(3):463-74. PubMed ID: 9515024
[TBL] [Abstract][Full Text] [Related]
14. p21(Cip1) and p27(Kip1) regulate cell cycle reentry after hypoxic stress but are not necessary for hypoxia-induced arrest.
Green SL; Freiberg RA; Giaccia AJ
Mol Cell Biol; 2001 Feb; 21(4):1196-206. PubMed ID: 11158306
[TBL] [Abstract][Full Text] [Related]
15. Multiple functions of p27(Kip1) and its alterations in tumor cells: a review.
Sgambato A; Cittadini A; Faraglia B; Weinstein IB
J Cell Physiol; 2000 Apr; 183(1):18-27. PubMed ID: 10699962
[TBL] [Abstract][Full Text] [Related]
16. E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1).
St Croix B; Sheehan C; Rak JW; Flørenes VA; Slingerland JM; Kerbel RS
J Cell Biol; 1998 Jul; 142(2):557-71. PubMed ID: 9679152
[TBL] [Abstract][Full Text] [Related]
17. A novel function of adenovirus E1A is required to overcome growth arrest by the CDK2 inhibitor p27(Kip1).
Alevizopoulos K; Catarin B; Vlach J; Amati B
EMBO J; 1998 Oct; 17(20):5987-97. PubMed ID: 9774342
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
[TBL] [Abstract][Full Text] [Related]
19. STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1).
de Koning JP; Soede-Bobok AA; Ward AC; Schelen AM; Antonissen C; van Leeuwen D; Löwenberg B; Touw IP
Oncogene; 2000 Jul; 19(29):3290-8. PubMed ID: 10918585
[TBL] [Abstract][Full Text] [Related]
20. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours.
Dahia PL; Aguiar RC; Honegger J; Fahlbush R; Jordan S; Lowe DG; Lu X; Clayton RN; Besser GM; Grossman AB
Oncogene; 1998 Jan; 16(1):69-76. PubMed ID: 9467944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]